Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 930

1.

Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation.

Yamagata K.

Curr Pharm Des. 2020 Apr 3. doi: 10.2174/1381612826666200403121952. [Epub ahead of print]

PMID:
32242776
2.

Anesthetic Management of a Patient With a Vagal Nerve Stimulator.

Yamagata K, Hirose Y, Tanaka K, Yoshida M, Ohnuki T, Sendo R, Niwa H, Sugimura M.

Anesth Prog. 2020 Spring;67(1):16-22. doi: 10.2344/anpr-66-03-02.

PMID:
32191509
3.

Are Intraoral Stents Effective for Reducing the Severity of Oral Mucositis During Radiotherapy for Maxillary and Nasal Cavity Cancer?

Inoue Y, Yamagata K, Nakamura M, Ohnishi K, Tabuchi K, Bukawa H.

J Oral Maxillofac Surg. 2020 Feb 13. pii: S0278-2391(20)30124-5. doi: 10.1016/j.joms.2020.02.009. [Epub ahead of print]

PMID:
32165135
4.

Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2020 Mar 7. doi: 10.1007/s10157-020-01864-1. [Epub ahead of print]

PMID:
32146646
5.

Postoperative delirium after reconstructive surgery for oral tumor: a retrospective clinical study.

Ishibashi-Kanno N, Takaoka S, Nagai H, Okubo-Sato M, Fukuzawa S, Uchida F, Yamagata K, Yanagawa T, Bukawa H.

Int J Oral Maxillofac Surg. 2020 Feb 27. pii: S0901-5027(20)30034-5. doi: 10.1016/j.ijom.2020.01.018. [Epub ahead of print]

PMID:
32115310
6.

Inhibitory effects of ceramide kinase on Rac1 activation, lamellipodium formation, cell migration, and metastasis of A549 lung cancer cells.

Tomizawa S, Tamori M, Tanaka A, Utsumi N, Sato H, Hatakeyama H, Hisaka A, Kohama T, Yamagata K, Honda T, Nakamura H, Murayama T.

Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jun;1865(6):158675. doi: 10.1016/j.bbalip.2020.158675. Epub 2020 Feb 26.

PMID:
32112978
7.

Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myeloma.

Tachita T, Kinoshita S, Ri M, Aoki S, Asano A, Kanamori T, Yoshida T, Totani H, Ito A, Kusumoto S, Komatsu H, Yamagata K, Kubo K, Tohkin M, Fukuda S, Iida S.

Cancer Sci. 2020 Feb 15. doi: 10.1111/cas.14352. [Epub ahead of print]

8.

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages.

Trimova G, Yamagata K, Iwata S, Hirata S, Zhang T, Uemura F, Satoh M, Biln N, Nakayamada S, Maksymowych WP, Tanaka Y.

Arthritis Res Ther. 2020 Feb 12;22(1):24. doi: 10.1186/s13075-020-2110-9.

9.

Constipation in CKD.

Sumida K, Yamagata K, Kovesdy CP.

Kidney Int Rep. 2019 Nov 13;5(2):121-134. doi: 10.1016/j.ekir.2019.11.002. eCollection 2020 Feb. Review.

10.

Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming.

Noguchi K, Ishida J, Kim JD, Muromachi N, Kako K, Mizukami H, Lu W, Ishimaru T, Kawasaki S, Kaneko S, Usui J, Ohtsu H, Yamagata K, Fukamizu A.

Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3150-3156. doi: 10.1073/pnas.1909124117. Epub 2020 Jan 28.

11.

Serotonin induces Arcadlin in hippocampal neurons.

Tanaka H, Sawano T, Konishi N, Harada R, Takeuchi C, Shin Y, Sugiura H, Nakatani J, Fujimoto T, Yamagata K.

Neurosci Lett. 2020 Mar 16;721:134783. doi: 10.1016/j.neulet.2020.134783. Epub 2020 Jan 22.

PMID:
31981722
12.

Mice lacking core 1-derived O-glycan in podocytes develop transient proteinuria, resulting in focal segmental glomerulosclerosis.

Fuseya S, Suzuki R, Okada R, Hagiwara K, Sato T, Narimatsu H, Yokoi H, Kasahara M, Usui T, Morito N, Yamagata K, Kudo T, Takahashi S.

Biochem Biophys Res Commun. 2020 Mar 19;523(4):1007-1013. doi: 10.1016/j.bbrc.2020.01.033. Epub 2020 Jan 20.

PMID:
31973821
13.

Chromosome segregation error during early cleavage in mouse pre-implantation embryo does not necessarily cause developmental failure after blastocyst stage.

Mashiko D, Ikeda Z, Yao T, Tokoro M, Fukunaga N, Asada Y, Yamagata K.

Sci Rep. 2020 Jan 21;10(1):854. doi: 10.1038/s41598-020-57817-x.

14.

Editing DNA Methylation in Mammalian Embryos.

Yamazaki T, Hatano Y, Taniguchi R, Kobayashi N, Yamagata K.

Int J Mol Sci. 2020 Jan 18;21(2). pii: E637. doi: 10.3390/ijms21020637. Review.

15.

Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase enhancer of zeste homolog 2.

Zhang M, Iwata S, Hajime M, Ohkubo N, Todoroki Y, Miyata H, Ueno M, Hao H, Zhang T, Fan J, Nakayamada S, Yamagata K, Tanaka Y.

Arthritis Rheumatol. 2020 Jan 21. doi: 10.1002/art.41208. [Epub ahead of print]

PMID:
31961063
16.

Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis.

Yamagata K.

J Cardiovasc Pharmacol. 2020 Apr;75(4):292-298. doi: 10.1097/FJC.0000000000000792.

PMID:
31895874
17.

Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.

Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Fujimoto S, Dobashi H, Yuzawa Y, Yamagata K, Muso E, Arimura Y, Makino H.

Mod Rheumatol. 2020 Jan 6:1-9. doi: 10.1080/14397595.2019.1707997. [Epub ahead of print]

PMID:
31859544
18.

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

Nakano T, Shiizaki K, Miura Y, Matsui M, Kosaki K, Mori S, Yamagata K, Maeda S, Kishi T, Usui N, Yoshida M, Onaka T, Mizukami H, Kaneda R, Karasawa K, Nitta K, Kurosu H, Kuro-O M.

Sci Rep. 2019 Dec 17;9(1):19247. doi: 10.1038/s41598-019-55643-4.

19.

Dietary Apigenin Reduces Induction of LOX-1 and NLRP3 Expression, Leukocyte Adhesion, and Acetylated Low-Density Lipoprotein Uptake in Human Endothelial Cells Exposed to Trimethylamine-N-Oxide.

Yamagata K, Hashiguchi K, Yamamoto H, Tagami M.

J Cardiovasc Pharmacol. 2019 Dec;74(6):558-565. doi: 10.1097/FJC.0000000000000747.

PMID:
31815868
20.

Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan.

Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.

PLoS One. 2019 Dec 4;14(12):e0225812. doi: 10.1371/journal.pone.0225812. eCollection 2019.

21.

Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up.

Usui J, Kai H, Kaneko S, Takahashi-Kobayashi M, Hagiwara M, Takahashi K, Oda T, Yamagata K.

CEN Case Rep. 2019 Dec 2. doi: 10.1007/s13730-019-00436-x. [Epub ahead of print]

22.

A simple method for sequencing the whole human mitochondrial genome directly from samples and its application to genetic testing.

Yao Y, Nishimura M, Murayama K, Kuranobu N, Tojo S, Beppu M, Ishige T, Itoga S, Tsuchida S, Mori M, Takayanagi M, Yokoyama M, Yamagata K, Kishita Y, Okazaki Y, Nomura F, Matsushita K, Tanaka T.

Sci Rep. 2019 Nov 22;9(1):17411. doi: 10.1038/s41598-019-53449-y.

23.

Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.

Yamamura S, Izumiya Y, Araki S, Nakamura T, Kimura Y, Hanatani S, Yamada T, Ishida T, Yamamoto M, Onoue Y, Arima Y, Yamamoto E, Sunagawa Y, Yoshizawa T, Nakagata N, Bober E, Braun T, Sakamoto K, Kaikita K, Morimoto T, Yamagata K, Tsujita K.

Hypertension. 2020 Jan;75(1):98-108. doi: 10.1161/HYPERTENSIONAHA.119.13357. Epub 2019 Nov 18.

PMID:
31735083
24.

A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.

Machida Y, Nakagawa M, Matsunaga H, Yamaguchi M, Ogawara Y, Shima Y, Yamagata K, Katsumoto T, Hattori A, Itoh M, Seki T, Nishiya Y, Nakamura K, Suzuki K, Imaoka T, Baba D, Suzuki M, Sampetrean O, Saya H, Ichimura K, Kitabayashi I.

Mol Cancer Ther. 2020 Feb;19(2):375-383. doi: 10.1158/1535-7163.MCT-18-1349. Epub 2019 Nov 14.

PMID:
31727689
25.

Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet's-like disease accompanied with myelodysplastic syndrome involving trisomy 8.

Tanaka N, Sakuraba H, Hiraga H, Mayama K, Kikuchi H, Kishida D, Akemoto Y, Hasui K, Ota S, Watanabe R, Murai Y, Maeda T, Kamata K, Tatsuta T, Sawaya M, Chinda D, Mikami T, Yamagata K, Ishiguro Y, Tanaka M, Fukuda S.

Immunol Med. 2019 Sep;42(3):135-141. doi: 10.1080/25785826.2019.1687251. Epub 2019 Nov 9.

PMID:
31707933
26.

Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.

Yokoyama N, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Hirano F, Sada KE, Matsumoto I, Kusaoi M, Amano H, Nagaoka S, Setoguchi K, Nagai T, Shimada K, Sugii S, Hashimoto A, Matsui T, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Migita K, Kono H, Hasegawa M, Kobayashi S, Yamada H, Nagasaka K, Sugihara T, Yamagata K, Ozaki S, Tamura N, Takasaki Y, Hashimoto H, Makino H, Arimura Y, Harigai M, Sato S, Sumida T, Tohma S, Takehara K, Tsuchiya N.

Sci Rep. 2019 Nov 8;9(1):16366. doi: 10.1038/s41598-019-52920-0.

27.
28.

A small number of residual teeth after the mandibular resection of oral cancer is associated with titanium reconstruction plate exposure.

Hirohata H, Yanagawa T, Takaoka S, Yamagata K, Sasaki K, Shibuya Y, Uchida F, Fukuzawa S, Tabuchi K, Hasegawa S, Ishibashi-Kanno N, Sekido M, Bukawa H.

Clin Exp Dent Res. 2019 Jun 7;5(5):469-475. doi: 10.1002/cre2.208. eCollection 2019 Oct.

29.

Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with cardiac resynchronization therapy devices.

Ueda N, Kamakura T, Noda T, Nakajima K, Kataoka N, Wada M, Yamagata K, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Izumi C, Noguchi T, Yasuda S, Kusano K.

J Cardiol. 2020 May;75(5):559-566. doi: 10.1016/j.jjcc.2019.10.001. Epub 2019 Oct 29.

PMID:
31672258
30.

Efficacy of a Device-Based Continuous Optimization Algorithm for Patients With Cardiac Resynchronization Therapy.

Ueda N, Noda T, Ishibashi K, Nakajima K, Kataoka N, Kamakura T, Wada M, Yamagata K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Yasuda S, Kusano K.

Circ J. 2019 Dec 25;84(1):18-25. doi: 10.1253/circj.CJ-19-0691. Epub 2019 Oct 26.

31.

Pulmonary Nodule in a Patient with Oral and Lung Cancer: Cryptococcus Infection.

Yamagata K, Hirano C, Kanno N, Uchida F, Fukuzawa S, Yanagawa T, Bukawa H.

Dent J (Basel). 2019 Oct 23;7(4). pii: E102. doi: 10.3390/dj7040102.

32.

Inhibition of Endothelial Dysfunction by Dietary Flavonoids and Preventive Effects Against Cardiovascular Disease.

Yamagata K, Yamori Y.

J Cardiovasc Pharmacol. 2020 Jan;75(1):1-9. doi: 10.1097/FJC.0000000000000757.

PMID:
31613843
33.

Cause-specific mortality in the general population with transient dipstick-proteinuria.

Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.

PLoS One. 2019 Oct 2;14(10):e0223005. doi: 10.1371/journal.pone.0223005. eCollection 2019.

34.

Cephalometric analysis of the pharyngeal airway space after maxillary advancement surgery.

Aoki J, Shinozuka K, Yamagata K, Nakamura R, Sato T, Ohtani S, Ogisawa S, Yanagawa K, Tonogi M.

J Oral Sci. 2019 Nov 27;61(4):529-533. doi: 10.2334/josnusd.18-0422. Epub 2019 Sep 20.

35.

Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study.

Naruse M, Mukoyama M, Morinaga J, Miyazaki M, Iseki K, Yamagata K.

Clin Exp Nephrol. 2020 Jan;24(1):45-52. doi: 10.1007/s10157-019-01789-4. Epub 2019 Sep 20.

PMID:
31541337
36.

A Prediction Model with Lifestyle in Addition to Previously Known Risk Factors Improves Its Predictive Ability for Cardiovascular Death.

Nishimoto M, Tagawa M, Matsui M, Eriguchi M, Samejima KI, Iseki K, Iseki C, Asahi K, Yamagata K, Konta T, Fujimoto S, Narita I, Kasahara M, Shibagaki Y, Moriyama T, Kondo M, Watanabe T, Tsuruya K.

Sci Rep. 2019 Sep 10;9(1):12953. doi: 10.1038/s41598-019-49003-5.

37.

Lower Diastolic Blood Pressure was Associated with Higher Incidence of Chronic Kidney Disease in the General Population Only in those Using Antihypertensive Medications.

Uchida D, Kido R, Kawarazaki H, Murasawa M, Ando A, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Konta T, Narita I, Kondo M, Kasahara M, Asahi K, Watanabe T, Shibagaki Y.

Kidney Blood Press Res. 2019;44(5):973-983. doi: 10.1159/000501828. Epub 2019 Sep 5.

38.

Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.

Shimada T, Yasuda S, Sugiura H, Yamagata K.

Int J Mol Sci. 2019 Aug 26;20(17). pii: E4171. doi: 10.3390/ijms20174171. Review.

39.

Association between p62 expression and clinicopathological characteristics in oral leukoplakia.

Yoshida T, Terabe T, Nagai H, Uchida F, Hasegawa S, Nagao T, Miyabe S, Ishibashi-Kanno N, Yamagata K, Warabi E, Gosho M, Yanagawa T, Bukawa H.

Clin Exp Dent Res. 2019 Jun 25;5(4):389-397. doi: 10.1002/cre2.193. eCollection 2019 Aug.

40.

Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10.

Tanaka K, Yamagata K, Kubo S, Nakayamada S, Sakata K, Matsui T, Yamagishi SI, Okada Y, Tanaka Y.

Bone. 2019 Nov;128:115034. doi: 10.1016/j.bone.2019.115034. Epub 2019 Aug 14.

PMID:
31421252
41.

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I.

Oncogene. 2019 Oct;38(42):6835-6849. doi: 10.1038/s41388-019-0929-9. Epub 2019 Aug 12.

PMID:
31406254
42.

Soy Isoflavones Inhibit Endothelial Cell Dysfunction and Prevent Cardiovascular Disease.

Yamagata K.

J Cardiovasc Pharmacol. 2019 Sep;74(3):201-209. doi: 10.1097/FJC.0000000000000708.

PMID:
31356541
43.

Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease.

Yamagata K.

Curr Pharm Des. 2019;25(22):2443-2458. doi: 10.2174/1381612825666190722100504.

PMID:
31333108
44.

Normal B cell development and Pax5 expression in Thy28/ThyN1-deficient mice.

Kitaura F, Yuno M, Fujita T, Wakana S, Ueda J, Yamagata K, Fujii H.

PLoS One. 2019 Jul 22;14(7):e0220199. doi: 10.1371/journal.pone.0220199. eCollection 2019.

45.

Computational fluid dynamics analysis for the preoperative prediction of airway changes after maxillomandibular advancement surgery.

Ogisawa S, Shinozuka K, Aoki J, Yanagawa K, Himejima A, Nakamura R, Yamagata K, Sato T, Suzuki M, Tanuma T, Tonogi M.

J Oral Sci. 2019 Aug 28;61(3):398-405. doi: 10.2334/josnusd.18-0130. Epub 2019 Jul 20.

46.

Comparing the catheter delivery system and the stylet delivery system for ventricular lead placement in pacemaker implantation-The CATS delivery system randomized controlled trial.

Yamagata K, Ishibashi K, Nakajima K, Kataoka N, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Noda T, Aiba T, Yasuda S, Kusano K.

J Arrhythm. 2019 Mar 29;35(3):524-527. doi: 10.1002/joa3.12179. eCollection 2019 Jun.

47.

Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up.

Kataoka N, Nagase S, Kamakura T, Nakajima K, Wada M, Yamagata K, Ishibashi K, Inoue YY, Miyamoto K, Noda T, Aiba T, Izumi C, Noguchi T, Yasuda S, Kamakura S, Kusano K.

Am J Cardiol. 2019 Sep 1;124(5):715-722. doi: 10.1016/j.amjcard.2019.05.067. Epub 2019 Jun 12.

PMID:
31284935
48.

Nuclear formation induced by DNA-conjugated beads in living fertilised mouse egg.

Suzuki Y, Bilir Ş, Hatano Y, Fukuda T, Mashiko D, Kobayashi S, Hiraoka Y, Haraguchi T, Yamagata K.

Sci Rep. 2019 Jun 11;9(1):8461. doi: 10.1038/s41598-019-44941-6.

49.

Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population.

Kudo A, Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M.

Sci Rep. 2019 Jun 3;9(1):8210. doi: 10.1038/s41598-019-44477-9.

50.

Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: a report from a collaborative initiative by six Japanese associations.

Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y.

Diabetol Int. 2019 Apr 25;10(2):85-92. doi: 10.1007/s13340-019-00389-7. eCollection 2019 Apr.

PMID:
31139526

Supplemental Content

Loading ...
Support Center